Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.3400 (1.52%) ($8.3400 - $8.3400) on Mon. Mar. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.32% (three month average) | RSI | 47 | Latest Price | $8.3400(1.52%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -4.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(30%) XLRE(24%) SDY(22%) IBB(21%) VWO(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.66% in a week (0% probabilities). VIXM(-10%) TLT(-9%) UUP(-8%) VXX(-7%) PCY(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.66% (StdDev 3.32%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.61(-167.27%) | Resistance Level | $9.1 | 5 Day Moving Average | $8.39(-0.6%) | 10 Day Moving Average | $8.6(-3.02%) | 20 Day Moving Average | $9.1(-8.35%) | To recent high | -29.6% | To recent low | 1.9% | Market Cap | $1.471b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |